Zocere, Inc.’s Stroke Drug To Be Featured At Biotechnology Industry Organization (BIO) Investor Forum

Each year 750,000 Americans suffer an acute ischemic stroke yet less than five percent receive pharmacologic treatment because of risks associated with the current therapy. New Mexico-based Zocere has a “brain protecting” drug it believes has the potential to be the first neuroprotectant on the market, and will be pitching the idea to investors at the BIO Investor Forum October 7 and 8 in San Francisco.

Help employers find you! Check out all the jobs and post your resume.